BNP Paribas Financial Markets’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-465,302
| Closed | -$1.95M | – | 4075 |
|
|
2023
Q1 | $1.95M | Buy |
465,302
+191,539
| +70% | +$994K | ﹤0.01% | 1829 |
|
|
2022
Q4 | $1.65M | Sell |
273,763
-56,043
| -17% | -$306K | ﹤0.01% | 1876 |
|
|
2022
Q3 | $1.92M | Buy |
329,806
+309,640
| +1,535% | +$1.93M | ﹤0.01% | 1989 |
|
|
2022
Q2 | $120K | Buy |
+20,166
| New | +$103K | ﹤0.01% | 3293 |
|
|
2020
Q2 | – | Sell |
-272
| Closed | -$250 | – | 4471 |
|
|
2020
Q1 | $250 | Hold |
272
| – | – | ﹤0.01% | 4171 |
|
|
2019
Q4 | $430 | Sell |
272
-5,827
| -96% | -$5.52K | ﹤0.01% | 4260 |
|
|
2019
Q3 | $5.11K | Hold |
6,099
| – | – | ﹤0.01% | 4272 |
|
|
2019
Q2 | $5.24K | Sell |
6,099
-7,757
| -56% | -$7.16K | ﹤0.01% | 4238 |
|
|
2019
Q1 | $13.4K | Buy |
13,856
+12,954
| +1,436% | +$13.6K | ﹤0.01% | 3986 |
|
|
2018
Q4 | $662 | Sell |
902
-768
| -46% | -$1.26K | ﹤0.01% | 3975 |
|
|
2018
Q3 | $3.61K | Hold |
1,670
| – | – | ﹤0.01% | 4159 |
|
|
2018
Q2 | $8.32K | Buy |
+1,670
| New | +$7.31K | ﹤0.01% | 3870 |
|
|
2016
Q1 | – | Sell |
-1,909
| Closed | -$23.5K | – | 3505 |
|
|
2015
Q4 | $23.5K | Sell |
1,909
-1,494
| -44% | -$19.9K | ﹤0.01% | 2803 |
|
|
2015
Q3 | $49.7K | Buy |
3,403
+2,034
| +149% | +$35.1K | ﹤0.01% | 2869 |
|
|
2015
Q2 | $26.7K | Buy |
1,369
+1,019
| +291% | +$19.7K | ﹤0.01% | 2863 |
|
|
2015
Q1 | $6.34K | Buy |
+350
| New | +$7.88K | ﹤0.01% | 3016 |
|
|
2014
Q4 | – | Sell |
-822
| Closed | -$19.9K | – | 4113 |
|
|
2014
Q3 | $19.9K | Buy |
+822
| New | +$21.4K | ﹤0.01% | 3170 |
|
|
2014
Q2 | – | Sell |
-13
| Closed | -$389 | – | 4088 |
|
|
2014
Q1 | $389 | Sell |
13
-133
| -91% | -$4.54K | ﹤0.01% | 3091 |
|
|
2013
Q4 | $2.81K | Sell |
146
-3,003
| -95% | -$54.7K | ﹤0.01% | 3469 |
|
|
2013
Q3 | $51K | Sell |
3,149
-1,354
| -30% | -$15.7K | ﹤0.01% | 2507 |
|
|
2013
Q2 | $47.3K | Buy |
+4,503
| New | +$52.8K | ﹤0.01% | 2676 |
|
Other funds holding CTIC
BNP Paribas Financial Markets's CTIC Position: Q2 2023 in Review
BNP Paribas Financial Markets sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2023, closing a stake of 465,302 shares — an estimated $1.95M sold.
BNP Paribas Financial Markets first reported a position in CTIC in Q2 2013 and held it in 21 quarters. The position peaked at $1.95M in Q1 2023. 2 funds tracked by Wall St. Rank hold CTIC as of Q2 2023.
- BNP Paribas Financial Markets reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2023 after selling out during the quarter.
- BNP Paribas Financial Markets sold 465,302 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2023, an estimated $1.95M.
- BNP Paribas Financial Markets first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 21 quarters.
- BNP Paribas Financial Markets's CTI BioPharma Corp. (DE) Common Stock position peaked at $1.95M in Q1 2023.
- 2 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2023.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2023, filed 9 Aug 2023.